Insider Shareholders with Direct Ownership of Seres Therapeutics, Inc. (MCRB)
This section provides a comprehensive overview of the insiders with direct ownership of Seres Therapeutics, Inc. (MCRB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Seres Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
David Arkowitz
Chief Financial Officer |
177,326 | 8,005 | 182,442 $175,144 | 8 |
Feb 16, 2024
Reduced 2.11%
|
|
Eric D. Shaff
CEO and President |
173,854 | 36,307 | 170,389 $163,573 | 13 |
Nov 18, 2024
Reduced 1.45%
|
|
Thomas Des Rosier
Chief Legal Officer and EVP |
109,086 | 14,948 | 135,192 $129,784 | 13 |
Nov 18, 2024
Reduced 0.65%
|
| 126,314 | 35,910 | 90,404 $86,787 | 14 |
Nov 18, 2024
Reduced 0.81%
|
|
| 172,363 | 106,593 | 77,770 $74,659 | 15 |
Nov 18, 2024
Reduced 1.18%
|
|
| 100,919 | 23,344 | 77,575 $74,472 | 13 |
Aug 16, 2024
Reduced 1.43%
|
|
| 63,492 | 0 | 63,492 $60,952 | 1 |
Jul 05, 2022
Added 50.0%
|
|
| 47,619 | 0 | 47,619 $45,714 | 1 |
Jul 05, 2022
Added 50.0%
|
|
|
Paula Cloghessy
Officer |
41,164 | 2,904 | 45,684 $43,856 | 3 |
Oct 30, 2023
Reduced 5.98%
|
| 48,270 | 15,855 | 32,415 $31,118 | 12 |
Nov 18, 2024
Reduced 2.93%
|
|
| 31,746 | 0 | 31,746 $30,476 | 1 |
Jul 05, 2022
Added 50.0%
|
|
|
Meryl Zausner
Director |
31,746 | 0 | 31,746 $30,476 | 1 |
Jul 05, 2022
Added 50.0%
|
| 3,589 | 0 | 3,589 $3,445 | 1 |
Nov 23, 2020
Added 50.0%
|